))
Episode 162: Oral vs transdermal estrogen and risk of blood clot
Manage episode 398053588 series 3526899
Content provided by Carolyn Moyers, DO, FACOG, MSCP, IF, Carolyn Moyers, DO, FACOG, MSCP, and IF. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Carolyn Moyers, DO, FACOG, MSCP, IF, Carolyn Moyers, DO, FACOG, MSCP, and IF or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Which route is right for you? Nonoral delivery systems of estradiol bypass the first pass effect. While oral estrogen therapy has been associated with increased factors the cause blood clots, transdermal estrogen appears to have a suppressive effect on these markers. Postmenopausal estrogen therapy involves a nuanced understanding of the mode of administration, individual risk factors, and the latest research findings. Seek a menopause society certified practioner (MSCP) in your area. **This is not medical advice, just medical education. Please ask your doctor medical questions as they pertain to your specific situation. Educational purposes only. .......................................................................... Welcome to the Sky Women community where we are all stronger together. COME SAY HI!!! Instagram: https://www.instagram.com/skywomenshealth https://www.instagram.com/drcarolynmoyers Facebook: https://www.facebook.com/skywomenshealth Email: hello@skywomenshealth.com Sky Women’s Health: Https://www.skywomenshealth.com 1125 S Henderson St, Fort Worth, TX 76104 To become a patient: email hello@skywomenshealth.com or call 817-915-9803. #EstrogenSafety #HormoneTherapyInsights #BloodClotRisk #TransdermalvsOral #MenopauseHealth #HormoneDeliverySystems #ACOGGuidelines #WomenHealthPodcast #skywomenshealth --- Send in a voice message: https://podcasters.spotify.com/pod/show/skywomenshealth/message
…
continue reading
183 episodes
Share
